How to Lose Weight on Antipsychotics

Losing weight while taking antipsychotics is harder than typical weight loss, but a growing body of evidence shows it is achievable through a layered approach combining dietary changes, physical activity, medication adjustments, and sometimes add-on drugs like metformin or newer GLP-1 medications. A meta-analysis of behavioral interventions found that people on antipsychotics who received structured support lost about 3 kg more than those who did not, and combining lifestyle changes with metformin has produced even larger results. The challenge is real, though, because these medications do not just increase appetite; they alter brain chemistry in ways that actively promote fat storage and metabolic disruption.

Why Antipsychotics Cause Weight Gain in the First Place

Understanding the enemy helps you fight it. Antipsychotics block dopamine receptors to control psychotic symptoms, but most of them also latch onto histamine, serotonin, and other receptors that have nothing to do with psychosis and everything to do with appetite and metabolism. The biggest culprit is the H1 histamine receptor. Research has shown that a drug’s affinity for this receptor is the single strongest predictor of whether it will cause weight gain, correctly classifying 15 out of 17 antipsychotics into “weight-gaining” and “non-weight-gaining” groups based on that one receptor alone.¹

When an antipsychotic blocks H1 receptors in the brain’s hypothalamus, it flips on an energy-sensing enzyme called AMP-kinase. In animal studies, this activation drives hunger and promotes calorie storage. Mice genetically engineered to lack H1 receptors did not gain weight on the same drugs.² On top of this, these drugs affect hormones that regulate hunger and fullness. Leptin, ghrelin, and adiponectin all get thrown off, with longer-term studies consistently showing elevated ghrelin levels in patients on weight-gain-prone antipsychotics.³ Some of these same medications also bind to serotonin 2C, muscarinic, and adrenergic receptors, each of which contributes to metabolic disruption in its own way.⁴

The practical takeaway is that this weight gain is not simply about eating too much. Your brain’s appetite thermostat has been physically adjusted, your hunger hormones are sending louder signals, and your body is more inclined to store fat. Knowing this matters because it means standard “eat less, move more” advice, while helpful, may need to be combined with other strategies to produce meaningful results.

Which Antipsychotics Carry the Most Risk

The difference between antipsychotics is dramatic. A large network meta-analysis comparing 18 antipsychotics found that clozapine caused the most weight gain compared to placebo, averaging about 3 kg, while olanzapine produced the highest increase in BMI. On the other end, aripiprazole, brexpiprazole, cariprazine, lurasidone, and ziprasidone had the most favorable metabolic profiles.⁵ A separate meta-analysis specifically examining which drugs were most likely to cause excessive weight gain (defined as gaining 7% or more of body weight) ranked olanzapine as having an 88% chance of producing the largest effect.⁶

Dose matters too. A dose-response meta-analysis found that nearly all antipsychotics show a relationship between dose and weight gain, though the shape of that relationship varies. Some drugs plateau at a certain dose, meaning going higher does not cause much more weight gain. Others keep climbing. Olanzapine fell into the “keeps climbing” category, while lurasidone showed a curve that rose and then leveled off.⁷ If you are on a high dose of a high-risk medication, this is important information to bring to your prescriber.

Starting Early Makes a Huge Difference

Weight gain tends to happen fast after starting an antipsychotic and continues accumulating over time.⁸ This rapid initial gain is important because it is far easier to prevent weight gain than to reverse it once it has happened. If you are newly starting one of these medications, the evidence strongly favors acting immediately rather than waiting to see what happens.

Clinical guidelines recommend regular monitoring from the start, including weight, waist circumference, blood pressure, fasting glucose, and blood lipids.⁹ In practice, this monitoring happens less often than it should.¹⁰ Tracking your own weight weekly and flagging a gain of more than 5% puts you in a better position to push for changes before the problem compounds.

Lifestyle Changes That the Evidence Supports

Diet and exercise interventions work for people on antipsychotics, but the magnitude of benefit depends heavily on how structured and sustained the program is. A meta-analysis of 17 randomized trials found that non-pharmacological interventions, ranging from nutritional counseling to cognitive behavioral therapy, reduced weight by about 3 kg and BMI by about 1 point compared to control groups.¹¹ A systematic review focused on exercise, diet, and educational programs similarly found consistent benefits across weight, BMI, waist circumference, and blood glucose levels.¹²

One especially striking trial looked at what happens when you start nutritional counseling at the same time as beginning olanzapine, one of the worst offenders for weight gain. The group that received no dietary guidance gained about 6 kg in three months and nearly 10 kg by six months. The group that got regular nutritional support gained only 2 kg at three months, and that number held at six months as well.¹³ The difference between 2 kg and 10 kg over half a year is dramatic, and it came from dietary changes alone, not medication switches or add-on drugs.

The most effective lifestyle programs in the research tend to share a few features. They involve regular contact with a nutritionist or health coach rather than a one-time pamphlet. They combine dietary guidance with structured physical activity rather than relying on either alone. And they often include some form of behavioral support, whether that is goal-setting, self-monitoring, or cognitive behavioral strategies. A trial published in JAMA found that lifestyle intervention alone reduced weight by about 1.4 kg over 12 weeks, while people on placebo without lifestyle support gained about 3 kg over the same period.¹⁴

Metformin as a First-Line Add-On

Metformin is the most studied medication for preventing and treating antipsychotic-related weight gain, and recent guidelines now formally recommend it. A Cochrane review and subsequent guideline development effort found that starting metformin at the same time as an antipsychotic reduced weight gain by roughly 3 to 4 kg compared to controls.¹⁵ It is the only pharmacological agent that has received a strong guideline recommendation for this purpose.

The JAMA trial mentioned above also tested metformin head to head with lifestyle changes. Metformin alone outperformed lifestyle changes alone, reducing weight by about 3.2 kg versus the 1.4 kg from lifestyle intervention. But the combination of both was the clear winner, with an average weight loss of about 4.7 kg over 12 weeks.¹⁴ The combination also improved insulin sensitivity and waist circumference more than either approach alone. If your prescriber has not discussed metformin with you, it is worth raising, especially if you are on one of the higher-risk antipsychotics.

GLP-1 Medications Are Entering the Picture

The newer GLP-1 receptor agonists, the same class of drugs behind semaglutide and liraglutide, are generating significant interest for antipsychotic-related weight gain. A meta-analysis of randomized trials found that GLP-1 medications reduced body weight by nearly 7 kg compared to controls in people taking antipsychotics, with semaglutide producing the largest effect at roughly 11 kg.¹⁶ Those numbers rival or exceed what GLP-1 drugs achieve in the general population, which is encouraging.

The evidence is still developing, though. A separate meta-analysis found a smaller effect that did not reach statistical significance, with a weight difference of about 5.9 kg favoring GLP-1 drugs but wide confidence intervals.¹⁷ A broader review described GLP-1 agonists as “promising” but noted that most non-metformin pharmacological options still rest on relatively low-confidence data.¹⁸

Real-world data from a large cohort study adds some nuance. People on antipsychotics who were prescribed incretin-based weight loss medications lost about 2 kg on average, and were roughly 70% more likely to achieve at least 5% weight loss than those who were not prescribed them. Interestingly, the weight loss was greater for people on lower-risk antipsychotics (about 3 kg) compared to those on higher-risk ones (about 1.3 kg).¹⁹ This suggests that the heaviest-hitting antipsychotics may partially blunt the effect of GLP-1 drugs, which is worth knowing if you are considering this option.

Switching to a Lower-Risk Antipsychotic

If lifestyle changes and add-on medications are not producing enough results, switching to an antipsychotic with a better metabolic profile is one of the most impactful interventions available. A systematic review and meta-analysis found that switching to aripiprazole produced about 5.5 kg of weight loss compared to staying on the original medication. Switching to ziprasidone also showed weight loss of about 2.2 kg. Meanwhile, switching to olanzapine or clozapine predictably caused more weight gain.²⁰

The catch is psychiatric stability. You cannot simply swap antipsychotics the way you would switch brands of ibuprofen. The same review found that dropout rates and psychosis ratings did not differ significantly between the switch and stay groups for aripiprazole, which is reassuring. But switching always carries some risk of relapse, especially for people whose current medication is controlling their symptoms well. This is a conversation that needs to happen with your psychiatrist, not a decision to make on your own. The question is whether the metabolic benefits outweigh the psychiatric risks, and the answer depends entirely on your individual situation.

Timing Your Dose May Matter

One of the more intriguing findings in recent years involves when you take your medication. Research in mice found that antipsychotics given at the start of the rest period caused significantly more weight gain and food intake than the same dose given before the active period. In human patients taking risperidone, those who took it in the evening before sleep for about a year gained more weight and had higher blood sugar markers than those who took it in the morning. The same study also found that time-restricted feeding, essentially limiting the window during which food was consumed, reduced antipsychotic-driven weight gain and blood glucose in the animal model.²¹

This research is still early, and it studied risperidone specifically, so it may not apply equally to every antipsychotic. Some of these medications cause sedation and are traditionally prescribed at night for that reason, which complicates things. Still, if you are on a medication that does not have strong sedating effects, asking your prescriber whether morning dosing might be feasible is a low-cost intervention worth exploring. The time-restricted eating angle is also worth considering, though you should clear any major dietary changes with your care team first.

Why Weight Gain Threatens the Treatment Itself

There is a vicious cycle at work here. Weight gain is not just a side effect to tolerate; it actively undermines the success of psychiatric treatment. A meta-analysis found that people who became overweight or obese were about 2.4 times more likely to stop taking their antipsychotic or become non-adherent compared to those at a normal weight.²² When people stop taking antipsychotics abruptly, the consequences can be severe, including relapse, hospitalization, and worsening long-term prognosis. This means that managing weight is not a vanity project or a secondary concern. It is directly tied to whether the underlying psychiatric treatment succeeds.

This framing can be useful when talking to your prescriber. If you have been gaining weight and feel like the medical team is not taking it seriously, the adherence data gives you a concrete argument: weight management is part of making the psychiatric medication work long-term.

Genetic Differences Explain Why Some People Gain More

If you are wondering why your friend takes the same antipsychotic and has not gained a pound while you have put on 15 kg, genetics is a big part of the explanation. Research has identified several genes that influence how susceptible a person is to antipsychotic-related weight gain. The most consistently replicated findings involve the melanocortin 4 receptor (MC4R) gene, the serotonin 2C receptor gene, and genes related to leptin, neuropeptide Y, and the cannabinoid receptor.²³ Underlying genetic variation can strongly affect how an antipsychotic alters gene expression in different individuals.²⁴

Pharmacogenomic testing, which screens your DNA for some of these variants, exists commercially but is not yet routine in psychiatric practice. It may become more useful as the evidence base matures. For now, the practical lesson is that individual variation is real and significant. If you are gaining weight rapidly on a particular antipsychotic, your biology may simply be more sensitive to that drug’s metabolic effects, and that is a legitimate reason to push for a different treatment strategy rather than blaming yourself for a lack of willpower.

The Gut Microbiome Connection

An emerging line of research links antipsychotic-related weight gain to changes in the gut microbiome. Systematic reviews in both humans and animal models have found consistent patterns: antipsychotics tend to reduce microbial diversity, shift the balance between major bacterial groups, and decrease levels of Akkermansia, a genus associated with healthy metabolism.²⁵ Research in children and adolescents starting antipsychotics has shown correlations between these gut changes and the weight gain that follows.²⁶

Whether manipulating the microbiome through probiotics, diet, or other means can actually reverse this weight gain is not yet clear. This is a field with more correlations than proven interventions. But it does offer another potential explanation for why high-fiber diets, which tend to support microbial diversity, may be especially helpful for people on these medications. It also underscores why the metabolic effects of antipsychotics go beyond simple calorie math.

Bariatric Surgery for Severe Cases

For people who have developed severe obesity while on antipsychotics and have not responded sufficiently to other interventions, bariatric surgery is not off the table. There has historically been reluctance to offer weight-loss surgery to people with serious mental illness, partly due to concerns about surgical complications and follow-through with post-operative lifestyle changes. But a study of patients with bipolar or schizoaffective disorders found that they actually achieved about 3.4% greater total weight loss over two years compared to matched controls without psychiatric diagnoses, after adjusting for starting weight. Rates of improvement in diabetes, high blood pressure, and sleep apnea were similar between the two groups.²⁷

Surgery is obviously a last resort, and it carries its own risks including interactions with medication absorption. But the finding that psychiatric patients do at least as well as others challenges the assumption that mental illness automatically rules out surgical options. If your weight has reached a point where it threatens your physical health, this is a conversation worth having with both your psychiatrist and a bariatric surgeon.

What Did Not Work

Not every pharmacological approach has panned out. Samidorphan, an opioid antagonist that was combined with olanzapine specifically to counteract weight gain, showed disappointing results. A meta-analysis of four randomized trials found no significant difference in weight change between the olanzapine-samidorphan combination and olanzapine alone.²⁸ Other agents that have been tried, including topiramate and histamine-2 receptor blockers, are supported only by low-confidence data.¹⁸ Knowing what does not work saves you from chasing supplements or off-label drugs that are unlikely to help, and lets you focus your energy on the strategies with the strongest backing.